Currently Viewing:
The American Journal of Managed Care October 2012
Change to FIT Increased CRC Screening Rates: Evaluation of a US Screening Outreach Program
Elizabeth G. Liles, MD, MSCR; Nancy Perrin, PhD; Ana Gabriela Rosales, MS; Adrianne C. Feldstein, MD, MS; David H. Smith, RPh, MHA, PhD; David M. Mosen, PhD, MPH; and Jennifer L. Schneider, MPH
Toward Tailored Disease Management for Type 2 Diabetes
Arianne M. J. Elissen, MSc; Inge G. P. Duimel-Peeters, PhD; Cor Spreeuwenberg, PhD; Marieke Spreeuwenberg, PhD; and Hubertus J. M. Vrijhoef, PhD
Currently Reading
Implementation of EHR-Based Strategies to Improve Outpatient CAD Care
Stephen D. Persell, MD, MPH; Janardan Khandekar, MD; Thomas Gavagan, MD; Nancy C. Dolan, MD; Sue Levi, RN, MBA; Darren Kaiser, MS; Elisha M. Friesema, BA, CCRP; Ji Young Lee, MS; and David W. Baker, MD, MPH
Medicare Part D Claims Rejections for Nursing Home Residents, 2006 to 2010
David G. Stevenson, PhD; Laura M. Keohane, MS; Susan L. Mitchell, MD, MPH; Barbara J. Zarowitz, PharmD, FCCP, BCPS, CGP, FASCP; and Haiden A. Huskamp, PhD
Identification of and Intervention to Address Therapeutic Gaps in Care
Daniel R. Touchette, PharmD, MA; Sapna Rao, BPharm, MS; Purna K. Dhru, PharmD; Weihan Zhao, PhD; Young-Ku Choi, PhD; Inderpal Bhandari, PhD; and Glen D. Stettin, MD
EMR-Based Medication Adherence Metric Markedly Enhances Identification of Nonadherent Patients
Shepherd Roee Singer, MD, MPH; Moshe Hoshen, PhD; Efrat Shadmi, PhD; Morton Leibowitz, MD; Natalie Flaks-Manov, MPH; Haim Bitterman, MD; and Ran D. Balicer, MD, PhD
Financial Incentives and Physician Commitment to Guideline-Recommended Hypertension Management
Sylvia J. Hysong, PhD; Kate Simpson, MPH; Kenneth Pietz, PhD; Richard SoRelle, BS; Kristen Broussard Smitham, MBA, MA; and Laura A. Petersen, MD, MPH
Identifying Frail Older People Using Predictive Modeling
Shelley A. Sternberg, MD; Netta Bentur, PhD; Chad Abrams, MA; Tal Spalter, MA; Tomas Karpati, MD; John Lemberger, MA; and Anthony D. Heymann, MB BS
Application of New Method for Evaluating Performance of Fracture Risk Tool

Implementation of EHR-Based Strategies to Improve Outpatient CAD Care

Stephen D. Persell, MD, MPH; Janardan Khandekar, MD; Thomas Gavagan, MD; Nancy C. Dolan, MD; Sue Levi, RN, MBA; Darren Kaiser, MS; Elisha M. Friesema, BA, CCRP; Ji Young Lee, MS; and David W. Baker, MD, MPH
We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.
Objectives: To evaluate the effects of a multifaceted quality improvement intervention during 2 time periods on 4 coronary artery disease [CAD] measures in 4 primary care practices. During the first phase, electronic reminders prompted physicians to order indicated medications or record contraindications and refusals (exceptions). In the second phase, physicians also received reports about their performance (including lists of patients not satisfying these measures), and financial incentives were announced.


Study Design: Time series analysis.


Methods: Adult CAD patients seen within the preceding 18 months were included. The primary outcome was the performance on each measure (proportion of eligible patients satisfying each measure after removing those with exceptions). Secondary outcomes were the proportion with the medication on their medication list, and the proportion with exceptions.


Results: Median performance at baseline was 78.8% for antiplatelet treatment, 85.1% for statin treatment, 77.0% for beta-blocker after myocardial infarction (MI), and 67.1% for angiotensinconverting enzyme inhibitor or angiotensin receptor blocker after MI. Performance improved slightly for 3 measures during the first phase and improved more substantially for all 4 measures during the second phase. For 3 of 4 measures, however, documentation of exceptions increased but not medication prescribing. Most exceptions were judged to be appropriate by peer review.


Conclusions: Physicians responded more to the combination of feedback and financial incentives than they had to electronic reminders alone. High performance was only achieved for 1 of 4 measures and recording of exceptions rather than increases in medication prescribing accounted for most of the observed improvements.


(Am J Manag Care. 2012;18(10):603-610)
We examined the sequential implementation of commonly used quality improvement techniques to improve outpatient coronary heart disease care in 4 practices.

 
  • Physician response to electronic reminders alone to address outpatient coronary heart disease measures was small.
 
  • Physicians responded more when the combination of feedback reports and financial incentives was added to reminders.
 
  • For 3 of 4 measures, documentation of exceptions increased, but not medication prescribing.
 
  • Most physician-recorded exceptions to quality measures were judged to be appropriate by peer review.
Quality improvement techniques that leverage an electronic health record (EHR) have been shown to improve care in many cases.1 However, EHR-based quality improvement has not been universally successful, and even in many instances where study results were positive, the magnitude of the improvement was small.2-4 Furthermore, observational data do not suggest that simply having an EHR improves quality in outpatient settings.5-7 In contrast, we have shown in the UPQUAL study (Utilizing Precision Performance Measurement for Focused Quality Improvement) that interconnected EHR-based tools can improve quality for multiple process of care measures in a large urban, single-site, university-affiliated practice.8 This intervention was designed to improve quality measurement (including capture of contraindications and patient refusals), make point-of-care reminders more accurate, and provide more valid and responsive feedback to clinicians (including lists of patients not receiving essential medications).

In this current study, we applied these principles—improve quality measurement in order to enable more accurate point-of-care reminders and feedback—to coronary artery disease (CAD) care in 4 suburban primary care group practices (2 family medicine and 2 internal medicine) that belong to the same health system and use the same EHR. We selected CAD care as our study objective because it is a common and important chronic disease and because implementing CAD measures in this setting was more feasible than several other candidate chronic disease and prevention topics. In this health system, point-of-care reminders were implemented first in July 2008 (Phase 1). Starting September to November 2009 (Phase 2), feedback was given to physicians and the medical group publicized to physicians that financial incentives would be tied to performance measures (including the 4 measures studied here). Both the reminders and physician feedback portions of the interventions were planned prior to Phase 1 by the study team. The financial incentives were initiated independently by leadership in the organization that was not directly associated with this study. This sequential implementation provides an opportunity to observe the additional effects of adding the combination of feedback and announcing financial incentives to electronic reminders on measured performance.

METHODS

Setting and Eligible Patients


We performed this study at 4 primary care practices in the northern suburbs of Chicago, Illinois, that use the same commercial EHR (EpicCare, Epic Systems Corporation, Verona, Wisconsin). Northwestern University’s and Northshore University HealthSystem’s institutional review boards approved the study. All patients eligible for 1 or more quality measures cared for by 33 attending physicians (10 family medicine and 23 internal medicine) and 15 family medicine resident physicians were included. The practices had used the EHR for 5 years before the start of the first intervention examined in the study.

Sequential Implementation of Quality Improvement Techniques

Measure Selection


We selected for consideration 4 measures of CAD care quality that were based on national measures: antiplatelet drug and lipid-lowering drug treatment in all patients with CAD, beta-blocker use in patients with prior myocardial infarction (MI), and angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) for diabetes or left ventricular systolic dysfunction.9 Health system clinicians, including cardiologists, discussed and modified the measures for local use, changing the lipid-lowering drug measure to statin treatment in CAD and changing the ACE inhibitor or ARB measure to apply to patients with prior MI only.

Electronic Clinical Decision Support (Phase 1)

Prior to these interventions, there were no other clinical decision support tools in use that addressed these topics. We added electronic point-of-care reminders that appeared during patient encounters when an apparently eligible patient did not have an indicated medication on their current medication list and had no exception recorded. These alerts were minimally intrusive (they did not interrupt clinicians’ work flow and the alert was indicated only by a single yellow highlighted tab that appeared on the left side of the screen when any clinical reminder criteria were present, and physicians had to select this tab to see the individual reminders). These alerts were displayed using existing EpicCare functionality. These electronic reminders included standardized ways to capture patient reasons (eg, refusals) or medical reasons that were exceptions for individual reminders within the reminder system of the EHR. These reminders were implemented in July 2008. We sent physicians educational e-mails with brief training materials to introduce the new alerts and to show how to record patient or medical exceptions.

Implementation of Feedback Reports and Announcement of Incentives (Phase 2)

Starting in September 2009, on a monthly basis, we gave physicians printed reports indicating their overall performance on each of the 4 measures for all their eligible patients and lists of individual patients who appeared to be eligible for an indicated medication but were not receiving it and had no exception recorded.

In October and November of 2009, the medical group leadership announced to physicians that a small portion of their compensation (1.5% of total compensation, which constituted 25% of the incentive-based compensation) would be tied to their performance on quality metrics, including the 4 metrics covered in this study.

Evaluation and Outcomes

Measure Calculation


We retrospectively calculated the performance for the 4 CAD measures for each month from September 2007 through March 2011. At each time point, patients were eligible for a measure if they had an office visit with a physician from 1 of the 4 included practices during the preceding 18 months and had a qualifying International Classification of Diseases, Ninth Revision, Clinical Modification code used on their active problem list, past medical history, or as an encounter diagnosis. We used Structured Query Language to retrieve data from an enterprise data warehouse that contains data copied daily from the EHR. For each time point, all patients were classified for each measure for which they were eligible as: a) satisfied, b) did not satisfy but had an exception, or c) did not satisfy and had no documented exception. The primary outcome for each measure was calculated as the number of patients who satisfied the measure divided by the total number of eligible patients excluding those with an exception. As an equation, the primary outcome = number satisfied / [number eligible – number not satisfied with an exception]. We also analyzed separately for each measure the proportion of eligible patients who satisfied the measure (were given the medication) and the proportion of all eligible patients who did not satisfy the measure and had exceptions.

Peer Review

We performed peer review beginning in September 2009 of medical exceptions recorded in the EHR and continued the review process for exceptions entered within the first 10 months of the intervention. One physician reviewed medical records to collect the reason for the exception and additional clinical information needed to judge the validity of the exception. When the clinical reasoning was unclear, the peer reviewer would request clarification from the treating clinician. Two board-certified internists and 1 board-certified family medicine physician met regularly to review the exceptions and judged them as appropriate, inappropriate (including when no contraindication to the medication was evident on physician chart review or cases where clarifying information was requested from the primary care physician but was not provided), or of uncertain appropriateness by consensus. When a consensus was not reached or the appropriateness was uncertain, 1 physician reviewed the medical literature, requested advice from specialists when needed, and the group discussed the case again until consensus was reached. Practice physicians received e-mail or telephone feedback for medical exceptions that were judged to be inappropriate.

Statistical Analysis

We used interrupted time series analysis to examine changes in the primary and secondary outcomes over time for 2 different interventions: before and after July 2008 (the transition between baseline and Phase 1), and before and after September 2009 (the transition between Phase 1 and Phase 2). We calculated the primary and secondary outcomes for each of the performance measures for each month from September 2007 through August 2010. A linear model was fit to each series including a continuous time variable, a dichotomous indicator of the intervention, and the interaction term of time and intervention as covariates. The individual data points used for each time period are depicted in the figures. Next, we determined the autoregressive order of the model residuals by minimizing Akaike’s information criterion.10 Finally, we fit a linear regression model with autoregressive errors (using the appropriate number of autoregressive parameters, if any were necessary) to each series. These fitted models were used to test statistical significance.11 To ensure model validity, we examined several residual diagnostics, the Jarque-Bera and the Shapiro-Wilk tests for normality of residuals, and normal Q-Q and autocorrelation plots.12-14 Analyses used SAS version 9.2 (SAS Institute Inc, Cary, North Carolina) and R software package version 2.13.1 (R Foundation for Statistical Computing, Vienna, Austria).

RESULTS

Patients and Their Characteristics


The number of patients eligible for the coronary disease measures and their characteristics are provided in Table 1. The number of eligible patients increased over time from 779 CAD and 218 MI patients in October 2007 to 1099 CAD and 332 MI patients by October 2010. Their characteristics changed little during the 3 years we examined (Table 1).

Performance During Baseline Period

Median performance during the baseline period was 78.9% for antiplatelet treatment, 85.3% for statin treatment, 77.0% for beta-blocker after MI, and 67.2% for ACE inhibitor or ARB after MI (Table 2). Performance on the antiplatelet measure was increasing significantly during the baseline period. Performance on the other 3 measures did not change significantly during the baseline period (Figures 1 and 2).

Performance During Phase 1

During Phase 1, overall performance continued to increase for the antiplatelet measure at a rate that was similar to the rate of improvement observed during the baseline period. There were statistically significant, but very small, increases in overall performance for the statin and ACE inhibitor/ARB measures (Table 2 and Figure 1). However, there were no significant increases in the rates of patients given medication for these 2 measures, and there was a decrease in patients given beta-blockers during Phase 1 compared with baseline (Table 2 and Figure 2). Physicians recorded exceptions to these measures during Phase 1 for small percentages of eligible patients (Figure 3).

Performance During Phase 2

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up